Aetna achieves over 81% of Medicare Advantage members in 4-Star plans and over 63% in 4.5-Star plans for 2026

, /PRNewswire/ --Â Aetna®, a CVS Health® company (NYSE: CVS), announced today that over 81 percent of its Medicare Advantage (MA) members are in 2026 Medicare Advantage Prescription Drug (MAPD) plans that are rated 4 stars or higher (out of 5 stars) by the Centers for Medicare & Medicaid Services (CMS). Additionally, over 63 percent of Aetna Medicare Advantage members are in a 4.5-star plan for 2026. "This year's Star Ratings reflect Aetna's strong fundamentals and unwavering commitment to delivering except ...